ARCHIVES

Intense Therapies Better Than Lower Dose For AML

This article is from The Cancer Letter archive.

Vol. 27 No. 11 | November 26, 2004

Download PDF Visit The Full Archive

Related Articles

Chemotherapy Patients Can Benefit From Heart Failure Treatment, Study Finds

October 25, 2002

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

September 29, 2006

Anticancer Vaccine Trials Due In Three-Four Years; Virus Research Opportunities Described

July 25, 1975

RPR Grant To NABCO Does Not Support Advocacy, Firm Says

November 10, 1995

Proton Beam Radiation Helps Cancer Patients Retain Vision

August 26, 2005

In Brief: Sullivan Rejects Oregon Medicaid Rationing Plan; Howe To Head National Marrow Donor Program

August 7, 1992